New Recommendations Released: Hospital Pharmacy
Feb 1, 2019 - News
The Canadian Society of Hospital Pharmacists announces the release of six new recommendations of tests, treatments or procedures to question in Hospital Pharmacy.
New Recommendations Released: Hospital Pharmacy
Feb 1, 2019 - News
The Canadian Society of Hospital Pharmacists announces the release of six new recommendations of tests, treatments or procedures to question in Hospital Pharmacy.
Under the leadership of the Canadian Society of Hospital Pharmacists, we are excited to announce the release of six new recommendations of tests, treatments or procedures to question in Hospital Pharmacy:
- Don’t continue medications that are no longer indicated or where the risks outweigh the benefits.
- Don’t use a medication for long-term risk reduction if life expectancy is shorter than the time to benefit of the medication.
- Don’t continue a proton pump inhibitor at discharge unless there is a compelling reason to continue therapy.
- Don’t start or prolong broad-spectrum antibiotic treatment unless clinically indicated.
- Don’t routinely prescribe benzodiazepines or other sedative-hypnotics for promotion of sleep without first a trial of non-pharmacologic interventions.
- Don’t initiate or escalate opioid doses for chronic non-cancer pain before optimizing non-opioid pharmacotherapy and non-pharmacologic therapy.
See Six Tests and Treatments to Question in Hospital Pharmacy to view the full list, including a rationale and references for each recommendation.
We encourage you to share broadly and thank you for your continued engagement in the Choosing Wisely Canada campaign!
Choosing Wisely Canada central team